New Market Perspective
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

New Market Perspective

Politics

Trump nominates Susan Monarez to become the next CDC director, says Americans ‘lost confidence’ in agency

by admin March 25, 2025
March 25, 2025
Trump nominates Susan Monarez to become the next CDC director, says Americans ‘lost confidence’ in agency

President Donald Trump has named Susan Monarez as his nominee for the next director of the Centers for Disease Control and Prevention (CDC), calling the candidate ‘a dedicated public servant.’

Monarez, who is currently acting director of the CDC, replaces Trump’s original nominee for the role, Dr. David Weldon. The Trump administration never gave an official reason why Weldon’s nomination was withdrawn earlier this month, but a source familiar with the matter told Fox News Digital that it would have been a ‘futile effort.’

‘It became clear that the votes weren’t there in the Senate for him to get confirmed,’ the source explained. ‘This would have been a futile effort.’

In a Truth Social post published on Monday, Trump wrote that Monarez ‘brings decades of experience championing Innovation, Transparency, and strong Public Health Systems.’

‘She has a Ph.D. from the University of Wisconsin, and PostDoctoral training in Microbiology and Immunology at Stanford University School of Medicine,’ the president wrote. ‘Dr. Monarez understands the importance of protecting our children, our communities, and our future.’

Trump also claimed that Americans have ‘lost confidence’ in the CDC, citing ‘political bias and disastrous mismanagement,’ as reasons why.

‘Dr. Monarez will work closely with our GREAT Secretary of Health and Human Services, Robert Kennedy Jr,’ the president continued. ‘Together, they will prioritize Accountability, High Standards, and Disease Prevention to finally address the Chronic Disease Epidemic and, MAKE AMERICA HEALTHY AGAIN!’

According to Monarez’s CDC biography, she previously worked at the White House in the Office of Science and Technology Policy and on the National Security Council.

‘[She led] efforts to enhance the nation’s biomedical innovation capabilities, including combating antimicrobial resistance, expanding the use of wearables to promote patient health, ensuring personal health data privacy, and improving pandemic preparedness,’ the biography states. ‘She has also held leadership positions at the Department of Homeland Security and has led numerous international cooperative initiatives to promote bilateral and multilateral health innovation research and development.’

Fox News Digital’s Rachel Wolf and Julia Johnson contributed to this report.

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
SCOOP: Mike Johnson meeting House Judiciary Committee as GOP mulls response to activist judges blocking Trump
next post
From ‘food justice’ to ‘useless surveys,’ Trump’s Cabinet reveals ‘nonsensical’ contracts it has canceled

Related Posts

New stealthy submarine glider set for autonomous undersea...

April 24, 2024

Senate unanimously passes bill bolstering presidential candidates’ Secret...

September 25, 2024

Israeli official praises Stefanik as UN pick, says...

November 12, 2024

Biden’s vax-focused COVID-19 website obliterated by White House,...

April 18, 2025

Pharmacist GOP Rep Carter urges Biden to take...

June 25, 2024

WH study warns 9 million Americans could lose...

May 18, 2025

Trump shooting task force says DHS, Secret Service...

December 11, 2024

GOP Rep Andy Barr endorses Trump for ‘strong...

December 19, 2023

Speaker Johnson to attend Trump trial in Manhattan...

May 15, 2024

Trump says Turkey ‘did an unfriendly takeover’ in...

December 17, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • At 90, the Dalai Lama braces for final showdown with Beijing: his reincarnation

      July 4, 2025
    • Russia becomes first nation to recognize Taliban government of Afghanistan since 2021 takeover

      July 4, 2025
    • Two arrested over ‘Chinese blessing scams’ targeting elderly Asian women in Australia

      July 4, 2025
    • Russia launches record number of drones at Ukraine after latest Trump-Putin phone call

      July 4, 2025
    • Elephant kills two female tourists from the UK and New Zealand in Zambian national park

      July 4, 2025
    • What is happening in South Korea? Seoul has caught the lovebug that nobody wants

      July 4, 2025

    Popular

    • 1

      Top 5 Junior Copper Stocks on the TSXV in 2023

      December 22, 2023
    • 2

      Canada Silver Cobalt Begins Drilling at Lowney-Lac Edouard in Quebec, Targeting Nickel-Copper-Cobalt Mineralization

      December 22, 2023
    • 3

      Crypto Market 2023 Year-End Review

      December 22, 2023
    • 4

      10 Top Oil-producing Countries (Updated 2024)

      October 19, 2024
    • 5

      Top 10 Uranium-producing Countries (Updated 2024)

      April 18, 2024
    • 6

      Powered by rain, this seed carrier could help reforest the most remote areas

      December 19, 2023
    • 7

      A troubling theory about traders profiting from Hamas’ attack on Israel drew much attention. Why it may not be so simple.

      December 13, 2023

    Categories

    • Business (1,398)
    • Investing (3,442)
    • Politics (4,517)
    • World (4,416)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: newmarketperspective.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 newmarketperspective.com | All Rights Reserved